The move is aimed at making these therapies accessible to a wider patient base in India, Novo Nordisk India head Vikrant Shrotriya told ET
Not to be used in children under 4 years of age without medical advice
What if the problem is sitting right there in your reconstitution step, hiding in plain sight, costing you potency every single week
While a direct causal relationship has not been established in humans, the medication comes with a warning to avoid use in individuals with a personal or family history of medullary thyroid carcinoma or in patients with Multiple Endocrine Neoplasia syndrome type 2
In 2021, the FDA reviewed a new drug application for the use of cabozantinib in patients aged 12 years and older with differentiated thyroid cancer because there are no standard-of-care treatments for this population after anti-VEGFR therapy, such as lenvatinib or sorafenib
The study's limitations include potential documentation biases, residual confounding, and the lack of granular data on smoking behavior, such as the number of cigarettes smoked per day and the severity of craving and withdrawal
